Patients with high levels of circulating endothelial progenitor cells (EPC) following at least three months of anticoagulation for unprovoked venous thromboembolism (VTE) are at low risk of recurrent VTE—Results from the ExACT randomised controlled trial.
Author:
Funder
National Institute for Health Research
South Warwickshire Haematology fund
Publisher
Elsevier BV
Subject
General Medicine
Reference34 articles.
1. Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study;Baglin;Lancet,2003
2. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report;Kearon;Chest,2016
3. Guidelines on oral anticoagulation with warfarin - fourth edition;Keeling;Br J Haematol,2011
4. Sex difference in the risk of recurrent venous thrombosis: a detailed analysis in four European cohorts;Roach;J Thromb Haemost,2015
5. Systematic review: d-dimer to predict recurrent disease after stopping anticoagulant therapy for unprovoked venous thromboembolism;Verhovsek;Ann Intern Med,2008
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Potentials of Endothelial Colony-Forming Cells: Applications in Hemostasis and Thrombosis Disorders, from Unveiling Disease Pathophysiology to Cell Therapy;Hämostaseologie;2023-10
2. Post-COVID-19 patients show an increased endothelial progenitor cell production;Translational Research;2022-05
3. Predicting the Risk of Recurrent Venous Thromboembolism: Current Challenges and Future Opportunities;Journal of Clinical Medicine;2020-05-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3